IBDEI26F ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36919,2)
 ;;=^5008245
 ;;^UTILITY(U,$J,358.3,36920,0)
 ;;=J45.41^^137^1778^24
 ;;^UTILITY(U,$J,358.3,36920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36920,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,36920,1,4,0)
 ;;=4^J45.41
 ;;^UTILITY(U,$J,358.3,36920,2)
 ;;=^5008249
 ;;^UTILITY(U,$J,358.3,36921,0)
 ;;=J45.42^^137^1778^25
 ;;^UTILITY(U,$J,358.3,36921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36921,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,36921,1,4,0)
 ;;=4^J45.42
 ;;^UTILITY(U,$J,358.3,36921,2)
 ;;=^5008250
 ;;^UTILITY(U,$J,358.3,36922,0)
 ;;=J45.40^^137^1778^26
 ;;^UTILITY(U,$J,358.3,36922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36922,1,3,0)
 ;;=3^Moderate Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,36922,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,36922,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,36923,0)
 ;;=J41.1^^137^1778^27
 ;;^UTILITY(U,$J,358.3,36923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36923,1,3,0)
 ;;=3^Mucopurulent Chr Bronchitis
 ;;^UTILITY(U,$J,358.3,36923,1,4,0)
 ;;=4^J41.1
 ;;^UTILITY(U,$J,358.3,36923,2)
 ;;=^269949
 ;;^UTILITY(U,$J,358.3,36924,0)
 ;;=J45.998^^137^1778^2
 ;;^UTILITY(U,$J,358.3,36924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36924,1,3,0)
 ;;=3^Asthma NEC
 ;;^UTILITY(U,$J,358.3,36924,1,4,0)
 ;;=4^J45.998
 ;;^UTILITY(U,$J,358.3,36924,2)
 ;;=^5008257
 ;;^UTILITY(U,$J,358.3,36925,0)
 ;;=J43.8^^137^1778^15
 ;;^UTILITY(U,$J,358.3,36925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36925,1,3,0)
 ;;=3^Emphysema NEC
 ;;^UTILITY(U,$J,358.3,36925,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,36925,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,36926,0)
 ;;=J43.1^^137^1778^28
 ;;^UTILITY(U,$J,358.3,36926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36926,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,36926,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,36926,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,36927,0)
 ;;=J45.51^^137^1778^29
 ;;^UTILITY(U,$J,358.3,36927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36927,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,36927,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,36927,2)
 ;;=^5008252
 ;;^UTILITY(U,$J,358.3,36928,0)
 ;;=J45.52^^137^1778^30
 ;;^UTILITY(U,$J,358.3,36928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36928,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,36928,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,36928,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,36929,0)
 ;;=J45.50^^137^1778^31
 ;;^UTILITY(U,$J,358.3,36929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36929,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,36929,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,36929,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,36930,0)
 ;;=J43.0^^137^1778^32
 ;;^UTILITY(U,$J,358.3,36930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36930,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,36930,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,36930,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,36931,0)
 ;;=J45.901^^137^1778^3
 ;;^UTILITY(U,$J,358.3,36931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36931,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,36931,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,36931,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,36932,0)
 ;;=J45.902^^137^1778^4
 ;;^UTILITY(U,$J,358.3,36932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36932,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,36932,1,4,0)
 ;;=4^J45.902
